(Q34357618)

1 August 2017

1 reference

title

Disease modifying drugs for rheumatoid arthritis: yesterday's treatment today or today's treatment tomorrow? (English)

1 reference

1 August 2017

1 reference

Pullar T

1

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 October 1990

1 reference

British Journal of Clinical Pharmacology

1 August 2017

published in

1 reference

1 August 2017

volume

30

1 reference

1 August 2017

issue

4

1 reference

1 August 2017

page(s)

501-510

1 reference

Gold Treatment in Rheumatoid Arthritis

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Hydroxychloroquine sulfate ("plaguenil") in treatment of rheumatoid arthritis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Chloroquine and rheumatoid arthritis; a short-term controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Penicillamine, a new oral therapy for Wilson's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Long‐term low dose haloperidol treatment in rheumatoid patients: effects on serum sulphydryl levels, technetium index, ESR, and clinical response [letter]

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Clinical judgment in rheumatoid arthritis. III. British rheumatologists' judgments of 'change in response to therapy'.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Oral gold for rheumatoid arthritis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Does second-line therapy affect the radiological progression of rheumatoid arthritis?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Non-steroidal analgesic and anti-inflammatory agents.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Comparison of phenytoin and gold as second line drugs in rheumatoid arthritis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

A controlled trial of nandrolone decanoate in the treatment of rheumatoid arthritis in postmenopausal women

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

The use of a pharmacological indicator to investigate compliance in patients with a poor response to antirheumatic therapy.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

A clinical and biochemical evaluation of etretinate in rheumatoid arthritis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Sulphasalazine alone or in combination with D-penicillamine in rheumatoid arthritis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Which component of sulphasalazine is active in rheumatoid arthritis?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Treatment of refractory rheumatoid arthritis--the thalidomide experience

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Feverfew in rheumatoid arthritis: a double blind, placebo controlled study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Corticosteroids in rheumatoid arthritis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Reforming the pyramid. A plan for treating rheumatoid arthritis in the 1990s

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Clinical, biochemical, and radiographic effects of aminohydroxypropylidene bisphosphonate treatment in rheumatoid arthritis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

What should we hope to achieve when treating rheumatoid arthritis?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Rational use of disease-modifying antirheumatic drugs

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Can we develop simple response criteria for slow acting antirheumatic drugs?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Salazopyrin in rheumatoid arthritis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Gold Therapy in Rheumatoid Arthritis: Final Report of a Multicentre Controlled Trial

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1990.TB03807.X

Salazopyrin in the Treatment of Rheumatoid Arthritis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1990.TB03807.X

Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Combined therapy of rheumatoid arthritis with gold and chloroquine. I. Evaluation of the therapeutic effect

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368239

Controlled multicenter trial of tiopronin and D-penicillamine for rheumatoid arthritis

27 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1990.TB03807.X

Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy

21 January 2018

1 reference

12 December 2020

A clinical and biochemical assessment of etidronate disodium in patients with active rheumatoid arthritis

1 reference

12 December 2020

Remodeling the pyramid--a concept whose time has not yet come

1 reference

12 December 2020

Are slow-acting antirheumatic drugs being given earlier in rheumatoid arthritis?

1 reference

12 December 2020

The effect of increasing fibrinolysis in patients with rheumatoid arthritis: a double blind study of stanozolol

1 reference

12 December 2020

Selection of suitable patients for second-line therapy in rheumatoid arthritis

1 reference

12 December 2020

Dapsone in rheumatoid arthritis

1 reference

12 December 2020

A human model screening system for the detection of specific antirheumatic activity

1 reference

12 December 2020

Study of sulphamethoxazole in rheumatoid arthritis

1 reference

12 December 2020

British Society for Rheumatology. Third annual general meeting. London, 19-22 November 1986. Abstracts

1 reference

12 December 2020

Cyclosporin A treatment of refractory rheumatoid arthritis

1 reference

12 December 2020

Effects of rifampicin with and without isoniazid in rheumatoid arthritis

1 reference

12 December 2020

Sulphasalazine versus hydroxychloroquine in rheumatoid arthritis: 3-year follow-up

1 reference

12 December 2020

Timegadine: more than a non-steroidal for the treatment of rheumatoid arthritis. A controlled, double-blind study

1 reference

12 December 2020

A comparison of therapies which may influence trace metals in rheumatoid arthritis

1 reference

12 December 2020

Captopril: a new treatment for rheumatoid arthritis?

1 reference

12 December 2020

Treatment of lupus erythematosus with mepacrine

1 reference

12 December 2020

Double-blind, placebo-controlled study of OM-8980 in rheumatoid arthritis

1 reference

12 December 2020

1H nuclear magnetic resonance investigation of synovial fluid components in osteoarthritis, rheumatoid arthritis and traumatic effusions

1 reference

12 December 2020

A clinical and biochemical assessment of a nonthiol ACE inhibitor (pentopril; CGS-13945) in active rheumatoid arthritis

1 reference

12 December 2020

Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis

1 reference

12 December 2020

Treatment of rheumatoid arthritis with desferrioxamine

1 reference

12 December 2020

Ciprofloxacin and rheumatoid arthritis--lack of effect

1 reference

12 December 2020

Second line therapy in rheumatoid arthritis--a four year prospective study

1 reference

12 December 2020

A study to determine the active moiety of sulphasalazine in rheumatoid arthritis

1 reference

12 December 2020

10.1111/J.1365-2125.1990.TB03807.X

Identifiers

DOI

1 reference

1 August 2017

1 reference

1 August 2017

1 reference